From human genes to stem cells: New challenges for patent law?

Trends in Biotechnology

Volumn 21, Issue 3, 2003, Pages 101-103

  Caulfield, Timothy A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; GENES; PATENTS AND INVENTIONS; PUBLIC POLICY;

PATENT LAW; STEM CELLS;

CLONING;

CLONE;

CLONING; ETHNOLOGY; GENE; HUMAN; LAW; PATENT; POLICY; PRIORITY JOURNAL; RESEARCH; SHORT SURVEY; STEM CELL;

EID: 0037333780     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(03)00006-4     Document Type: Short Survey

References (22)

1. Canadian Biotechnology Advisory Committee (2002) Patenting of Higher Life Forms and Related Issues. Ottawa: Biotechnology Ministerial Coordinating Committee.
2. Nuffield Council on Bioethics (2002) The Ethics of Patenting DNA: A Discussion Paper, London: Nuffield Council on Bioethics, July.
3. Caulfield T., et al. Patenting human genetic material: refocusing the debate. Nat. Rev.Genet. 1:2000;227-231.
4. Commission on Intellectual Property Rights. (2002) Integrating Intellectual Property Rights and Development Policy. September.
5. Scheinfeld R., Bagley P. The Current State of Embryonic Stem Cell Patents. New York Law Journal. 27 September:2001.
6. Morrow J.D. Patentable Subject-Matter: Emerging Technologies. Henderson G.F. 1982;23-40 Patent Law of Canada, Toronto: Thomson Canada Ltd.
7. (1980), 206 U.S.P.Q. 193.
8. European Group on Ethics in Science and New Technologies (2002) Ethical Aspects of Patenting Inventions Involving Human Stem Cells, Opinion 16, 7 May.
9. Brower V. Human ES cells: Can you build a business around them? Nat. Biotech. 17:1999;139-142.
10. Scheinfeld R., Bagley P. The Current State of Embryonic Stem Cell Patents. New York Law Journal. 27 September:2001.
11. Schiermeier Q. Germany challenges human stem cell patent awarded 'by mistake'. Nature. 404:2000;3-4.
12. Abbott A., Schmidt O. Opponents of stem-cell patent win restrictions. Nature. 418:2002;470.
13. Nelkin D., Andrews L. Homo Economicus: Commercialization of Body Tissue in the Age of Biotechnology. Hastings Center Rep. 28:1998;30-39.
14. Pollack A. Debate on Human Cloning Turns to Patents. New York Times. 17 May:2002.
15. Ottawa: Biotechnology Assistant Deputy Minister Coordinating Committee (2001) Pollara Research & Earnscliffe Research and Communications. Public opinion research into biotechnology issues, 5th wave.
16. Edmonton Journal. A11:2002;. 11 May.
17. Stolberg S.G. US Rule on Stem Cell Studies Lets Researcher Use New Lines. New York Times. 7 August:2002.
18. Vogel G. In the Mideast, Pushing Back the Stem Cell Frontier. Science. 295:2002;1818.
19. Reich J. The Debate in Germany. Science. 296:2002;265.
20. Canadian Biotechnology Advisory Committee (2002) Patenting of Higher Life Forms and Related Issues. Ottawa: Biotechnology Ministerial Coordinating Committee, June.
21. Scheinfeld R., Bagley P. The Current State of Embryonic Stem Cell Patents. New York Law Journal. 27 September:2001.
22. Gillis J., Weiss R. Stem Cell Research Not Yet Booming. The Washington Post. 6 August:2002;A01.